alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 82, Number 184 (Monday, September 25, 2017)]
[Notices]
[Page 44683]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20360]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION


Submission for OMB Review; Comment Request

Upon Written Request Copies Available From: Securities and Exchange 
Commission Office of FOIA Services 100 F Street NE., Washington, DC 
20549-2736

Extension: Rule 173, SEC File No. 270-557, OMB Control No. 3235-0618

    Notice is hereby given that, pursuant to the Paperwork Reduction 
Act of 1995 (44 U.S.C. 3501 et seq.), the Securities and Exchange 
Commission (``Commission'') has submitted to the Office of Management 
and Budget this request for extension of the previously approved 
collection of information discussed below.
    Securities Act Rule 173 (17 CFR 230.173) provides a notice of 
registration to investors who purchased securities in a registered 
offering under the Securities Act of 1933 (15 U.S.C. 77a et seq.). A 
Rule 173 notice must be provided by each underwriter or dealer to each 
investor who purchased securities from the underwriter or dealer. The 
Rule 173 notice is not publicly available. We estimate that it takes 
approximately 0.0167 hour per response to provide the information 
required under Rule 173 and that the information is filed by 
approximately 5,338 respondents approximately 43,546 times a year for a 
total of 232,448,548 responses. We estimate that the total annual 
reporting burden for Rule 173 is 3,881,891 hours (0.0167 hours per 
response x 232,448,548 responses).
    An agency may not conduct or sponsor, and a person is not required 
to respond to, a collection of information unless it displays a 
currently valid control number.
    The public may view the background documentation for this 
information collection at the following Web site, www.reginfo.gov . 
Comments should be directed to: (i) Desk Officer for the Securities and 
Exchange Commission, Office of Information and Regulatory Affairs, 
Office of Management and Budget, Room 10102, New Executive Office 
Building, Washington, DC 20503, or by sending an email to: 
<a href="/cdn-cgi/l/email-protection#a7f4cfc6c0d2c1d3c6f8e6cfcac2c3e7c8cac589c2c8d789c0c8d1"><span class="__cf_email__" data-cfemail="3d6e555c5a485b495c627c555058597d52505f1358524d135a524b">[email protected]</span></a>; and (ii) Pamela Dyson, Director/Chief 
Information Officer, Securities and Exchange Commission, c/o Remi 
Pavlik-Simon, 100 F Street NE., Washington DC 20549 or send an email 
to: <a href="/cdn-cgi/l/email-protection#36666477697b575f5a54594e7645535518515940"><span class="__cf_email__" data-cfemail="5f0f0d1e00123e36333d30271f2c3a3c71383029">[email protected]</span></a>. Comments must be submitted to OMB within 30 
days of this notice.

    Dated: September 19, 2017.
Eduardo A. Aleman,
Assistant Secretary.
[FR Doc. 2017-20360 Filed 9-22-17; 8:45 am]
 BILLING CODE 8011-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
EXHIBIT 10.4

 

ENDORSEMENT TO 10% SENIOR SECURED CONVERTIBLE NOTE

 

Precision Optics Corporation, Inc.

New York, New York

February 7, 2011

 

The 10% Senior Secured Convertible Note dated June 25, 2008 and amended December 11, 2008, June 25, 2010, July 26, 2010, September 15, 2010, October 15, 2010, November 15, 2010, November 30, 2010, December 1, 2010 December 3, 2010, December 17, 2010, January 10, 2011 and January 24, 2011 (the “Note”) of Precision Optics Corporation, Inc., a Massachusetts corporation (the “Company”), payable to the order of Arnold Schumsky (the “Holder”) in an aggregate principal amount of $50,000 and to which this Endorsement is affixed is hereby amended in the following respects:

 

1.            The term “Stated Maturity Date” is hereby restated to be “February 25, 2011.”

 

2.                                       Except as expressly amended by this Endorsement, the Note remains in full force and effect and the Company hereby reconfirms its obligations thereunder.

 

IN WITNESS WHEREOF, the Company has caused this Endorsement to be duly executed, and the Holder has caused this Endorsement to be duly accepted, by their respective duly authorized representatives as of the day and year first above written.

 

	
 
    	
 
    	
 
    
	
 
    	
PRECISION   OPTICS CORPORATION, INC.
    
	
 
    	
 
    	
 
    
	
 
    	
By
    	
/s/   Richard E. Forkey
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Name:   Richard E. Forkey
    
	
 
    	
 
    	
Title:   Chief Executive Officer
    


 

	
Accepted:
    	
 
    
	
 
    	
 
    
	
 
    	
 
    
	
/s/   Arnold Schumsky
    	
 
    
	
 
    	
 
    
	
Arnold   Schumsky
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2690 Introduced in House (IH)]

112th CONGRESS
  1st Session
                                H. R. 2690

To amend title 40, United States Code, to direct the Inspector General 
 of the Department of Transportation to conduct an annual independent 
financial audit of the Union Station Redevelopment Corporation, and for 
                            other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             July 28, 2011

  Ms. Norton introduced the following bill; which was referred to the 
             Committee on Transportation and Infrastructure

_______________________________________________________________________

                                 A BILL

 
To amend title 40, United States Code, to direct the Inspector General 
 of the Department of Transportation to conduct an annual independent 
financial audit of the Union Station Redevelopment Corporation, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. UNION STATION REDEVELOPMENT CORPORATION.

    (a) Annual Financial Audit.--Subchapter I of chapter 69 of title 
40, United States Code, is amended by adding at the end the following:
``Sec. 6911. Annual financial audit of Union Station Redevelopment 
              Corporation
    ``(a) In General.--The Inspector General of the Department of 
Transportation shall conduct an annual audit of the financial 
statements of the Union Station Redevelopment Corporation.
    ``(b) Reports to Congress.--The Inspector General shall transmit to 
Congress an annual report containing the results of the most recent 
audit conducted under subsection (a).''.
    (b) Clerical Amendment.--The analysis for such subchapter is 
amended by adding at the end the following:

``6911. Annual financial audit of Union Station Redevelopment 
                            Corporation.''.
                                 <all>
```
<PAGE>
                                  EXHIBIT 23.1

                          INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in Registration Statement Nos.
33-71276, 33-94370, 333-83089, 333-84183 and 333-38094 on Form S-8 and
Registration Statement Nos. 33-49082, 33-76094, 333-24549, 333-76641, 333-77925,
333-31442, 333-32776, 333-34958 and 333-35934 on Form S-3 of AVANIR
Pharmaceuticals of our report dated December 24, 2002, appearing in this Annual
Report on Form 10-K of AVANIR Pharmaceuticals for the year ended September 30,
2002.

DELOITTE & TOUCHE LLP

San Diego, California
December 24, 2002
IN THE SUPREME COURT OF THE STATE OF MONTANA No. DA 23
- 0305 STATE OF MONTANA,

Plaintiff and Appellee, v. NEIL DENNIS COLE,

Defendant and Appellant
.

**ORDER** Upon consideration of Appellant’s motion for extension of time, and good cause appearing, IT IS HEREBY ORDERED that Appellant is granted an extension of time to and including July 12 , 2024, within which to prepare, file, and serve Appellant’s opening brief on appeal.

Electronically signed by: Mike McGrath Chief Justice, Montana Supreme Court

May 6 2024

05/06/2024

Case Number: DA 23-0305
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       3,192,000
<SECURITIES>                                         0
<RECEIVABLES>                                8,748,000
<ALLOWANCES>                                 2,325,000
<INVENTORY>                                  3,785,000
<CURRENT-ASSETS>                            19,115,000
<PP&E>                                      10,547,000
<DEPRECIATION>                               4,701,000
<TOTAL-ASSETS>                              31,768,000
<CURRENT-LIABILITIES>                        5,550,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    39,414,000
<OTHER-SE>                                     641,000
<TOTAL-LIABILITY-AND-EQUITY>                24,670,000
<SALES>                                     19,197,000
<TOTAL-REVENUES>                            29,784,000
<CGS>                                       11,824,000
<TOTAL-COSTS>                               25,331,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             404,000
<INCOME-PRETAX>                              4,049,000
<INCOME-TAX>                               (4,763,000)
<INCOME-CONTINUING>                          8,812,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 8,812,000
<EPS-BASIC>                                     0.61
<EPS-DILUTED>                                     0.58


</TABLE>
Exhibit 32.1


                                  CERTIFICATION
                       PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Jacobs  Financial  Group,  Inc.
(the  "Company")  on Form 10-K for the year  ended May 31,  2009 (the  "Report")
filed with the Securities and Exchange Commission,  I, John M. Jacobs, President
and Chief  Executive  Officer of the  Company,  certify,  pursuant  to 18 U.S.C.
Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that:

     (1)  The Company's  Report fully complies with the  requirements of Section
          13(a) or 15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.

Date: September 14, 2009

                                By:
                                   /s/John M. Jacobs
                                   ------------------------------------------
                                   John M. Jacobs, Chief Executive Officer
<PAGE>

                                                                    Exhibit 32.1




     CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
                            (18 U.S.C. SECTION 1350)


        In connection with the Quarterly Report on Form 10-Q of Aware, Inc. (the
"Company") for the quarter ended June 30, 2005, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), each of the undersigned
Chief Executive Officer and Chief Financial Officer of the Company, certifies,
to the best knowledge and belief of the signatory, pursuant to 18 U.S.C.
ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002,
that:

        (1)     The Report fully complies with the requirements of Section 13(a)
                or 15(d) of the Securities Exchange Act of 1934; and

        (2)     The information contained in the Report fairly presents, in all
                material respects, the financial condition and results of
                operations of the Company.


/s/ Michael A. Tzannes                                /s/ Robert J. Weiskopf
----------------------                                ----------------------
Chief Executive Officer                               Chief Financial Officer


Date:  August 9, 2005                                 Date: August 9, 2005


        The certification set forth above is being furnished as an exhibit
solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is not
being filed as part of the Form 10-Q or as a separate disclosure document of the
Company or the certifying officers.


                                       30
I 

112TH CONGRESS 

1ST SESSION H. R. 2893 

To prohibit Foreign Military Financing program assistance to countries that 

vote in the United Nations General Assembly in favor of recognizing 

a Palestinian state in the absence of a negotiated border agreement 

between the Government of Israel and the Palestinian Authority. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 12, 2011 

Mr. ISRAEL (for himself, Mr. BRADY of Pennsylvania, Mr. ENGEL, and Mr. 

ROTHMAN of New Jersey) introduced the following bill; which was referred to the Committee on Foreign Affairs 

A BILL 

To prohibit Foreign Military Financing program assistance 

to countries that vote in the United Nations General 

Assembly in favor of recognizing a Palestinian state in 

the absence of a negotiated border agreement between 

the Government of Israel and the Palestinian Authority. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


emcdonald on DSK5VPTVN1PROD with BILLS
2 

•HR 2893 IH

1 SECTION 1. PROHIBITION ON FOREIGN MILITARY FINANC2 ING PROGRAM ASSISTANCE TO COUNTRIES 

3 THAT VOTE IN THE UNITED NATIONS GEN4 ERAL ASSEMBLY IN FAVOR OF RECOGNIZING 

5 A PALESTINIAN STATE IN THE ABSENCE OF A 

6 NEGOTIATED BORDER AGREEMENT BE7 TWEEN THE GOVERNMENT OF ISRAEL AND 

8 THE PALESTINIAN AUTHORITY. 

9 (a) PROHIBITION.—Notwithstanding any other provi10 sion of law, assistance under section 23 of the Arms Ex11 port Control Act (22 U.S.C. 2763; relating to the ‘‘For12 eign Military Financing’’ program) may not be provided 

13 to any country that votes in the United Nations General 

14 Assembly in favor of recognizing a Palestinian state in the 

15 absence of a negotiated border agreement between the 

16 Government of Israel and the Palestinian Authority. 

17 (b) WAIVER.—The President may waive the prohibi18 tion in subsection (a) on a case-by-case basis if the Presi19 dent certifies to the Speaker and minority leader of the 

20 House of Representatives and the majority and minority 

21 leaders of the Senate not later than 30 days after issuing 

22 the waiver that it is in the national interests of the United 

23 States to do so. 

24 (c) EFFECTIVE DATE.—This Act takes effect on the 

25 date of the enactment of this Act and applies with respect 

26 to assistance under section 23 of the Arms Export Control 


emcdonald on DSK5VPTVN1PROD with BILLS
3 

•HR 2893 IH

1 Act that is made available for fiscal years beginning after 

2 fiscal year 2011. 

Æ 


emcdonald on DSK5VPTVN1PROD with BILLS
**Exhibit 23.1****CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**We consent to the incorporation by reference in Registration Statements No. 33-71276, 33-94370,333-83089, 333-84183, 333-38094, 333-108716 and 333-125743 on Form S-8 and Registration StatementsNo. 33-49082, 33-76094, 333-24549, 333-76641, 333-77925, 333-31442, 333-32776, 333-34958,333-35934, 333-107820, 333-111680, 333-114389, 333-123867, 333-124230 and 333-125979 on Form S-3 ofour reports dated December 14, 2006, relating to the financial statements of AVANIR Pharmaceuticals(which report expresses an unqualified opinion and includes an explanatory paragraphrelating to the adoption of Statement of Financial Accounting Standards No. 123(R),*Share-based Payment,*and the change in method of accounting for certain patent related costs,effective October 1, 2005) and management’s report on the effectiveness of internal controlover financial reporting, appearing in this Annual Report on Form 10-K of AVANIR Pharmaceuticalsfor the year ended September 30, 2006./s/ DELOITTE & TOUCHE LLPSan Diego, California
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Center for Scientific Review Special Emphasis Panel, Psychosocial Risk and Disease Prevention.                    

*Date:*                         September 26, 2017.                    

*Time:*                         8:00 a.m. to 12:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW.,  Washington, DC 20015.                    

*Contact Person:*                         Marc Boulay, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3110, MSC 7808, Bethesda, MD 20892, (301) 300-6541,                         *boulaymg@csr.nih.gov*.                    

This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

Dated: September 8, 2017.

Anna Snouffer,

Deputy Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2017-19411 Filed 9-12-17; 8:45 am]

BILLING CODE 4140-01-P
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THE COMPANY'S REGISTRATION STATEMENT ON FORM SB-2, FILE NO. 333-09349
</LEGEND>
       
<S>                                 <C>                  <C>
<PERIOD-TYPE>                       YEAR                 6-MOS
<FISCAL-YEAR-END>                         DEC-31-1996         DEC-31-1997
<PERIOD-END>                              DEC-31-1996         JUN-30-1997
<CASH>                                     20,968,831           9,707,661
<SECURITIES>                                        0           8,182,100
<RECEIVABLES>                                       0                   0
<ALLOWANCES>                                        0                   0
<INVENTORY>                                         0                   0
<CURRENT-ASSETS>                           21,952,624          19,175,400
<PP&E>                                              0              71,689
<DEPRECIATION>                                      0               7,589
<TOTAL-ASSETS>                             23,084,002          19,239,500
<CURRENT-LIABILITIES>                       1,209,231           1,405,134
<BONDS>                                             0                   0
<PREFERRED-MANDATORY>                               0                   0
<PREFERRED>                                     2,592               2,449
<COMMON>                                       11,857              14,073
<OTHER-SE>                                 20,729,249          17,834,366
<TOTAL-LIABILITY-AND-EQUITY>               20,743,698          19,239,500
<SALES>                                             0                   0
<TOTAL-REVENUES>                                    0                   0
<CGS>                                               0                   0
<TOTAL-COSTS>                                       0                   0
<OTHER-EXPENSES>                              460,259             463,359
<LOSS-PROVISION>                                    0                   0
<INTEREST-EXPENSE>                            206,222             (81,238)
<INCOME-PRETAX>                              (505,077)                  0
<INCOME-TAX>                                        0                   0
<INCOME-CONTINUING>                                 0                   0
<DISCONTINUED>                                      0                   0
<EXTRAORDINARY>                                     0                   0
<CHANGES>                                           0                   0
<NET-INCOME>                                 (505,077)         (2,098,301)
<EPS-PRIMARY>                                   (0.27)               (.62)
<EPS-DILUTED>                                       0                   0
        





</TABLE>